Cutia Therapeutics (HKG:2487)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.340
-0.060 (-2.50%)
Jul 31, 2026, 3:44 PM HKT

Cutia Therapeutics Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
265.01385.67473.12465.87203.13
Short-Term Investments
91.7510.53330.19567.15769.65
Trading Asset Securities
431.49479.96469.3443.5405.49
Cash & Short-Term Investments
788.24876.161,2731,0771,378
Cash Growth
-10.03%-31.16%18.22%-21.89%-
Accounts Receivable
183.3100.5363.51.340.5
Other Receivables
17.024.2213.472.780
Receivables
200.32104.7576.974.120.5
Inventory
35.4674.6945.31201.8
Restricted Cash
0.59----
Other Current Assets
18.0431.5321.3844.821.15
Total Current Assets
1,0431,0871,4161,1451,402
Property, Plant & Equipment
204.81220.93226.01229.0150.79
Other Intangible Assets
8.148.97.810.60.22
Long-Term Accounts Receivable
7.188.619.9711.274.03
Other Long-Term Assets
8.7834.4114.9530.2326.86
Total Assets
1,3061,3931,7071,4471,495

Liabilities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
15.3612.8220.29-0.34
Accrued Expenses
22.2132.9634.8417.8812.19
Short-Term Debt
97.88173.389.41--
Current Portion of Long-Term Debt
68.764040--
Current Portion of Leases
15.5612.3811.378.833.72
Current Income Taxes Payable
7.226.571.340.960.63
Current Unearned Revenue
--0.4--
Other Current Liabilities
42.7345.2357.1349.732.39
Total Current Liabilities
269.72323.25254.7977.419.25
Long-Term Debt
84.5750602,5702,243
Long-Term Leases
50.6345.2642.9745.322.82
Long-Term Unearned Revenue
16.09--0.40.4
Total Liabilities
421418.51357.762,6932,285

Shareholders' Equity

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.050.050.040.010.01
Additional Paid-In Capital
4,9164,6914,686259.16259.16
Retained Earnings
-3,724-3,384-2,950-986.11-430.28
Treasury Stock
-13.86-13.86---
Comprehensive Income & Other
-292.62-318.41-387.02-519.37-619.4
Shareholders' Equity
885.28974.731,349-1,246-790.51
Total Liabilities & Equity
1,3061,3931,7071,4471,495

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
317.39320.94243.762,6242,269
Net Cash (Debt)
470.85555.221,029-1,548-891.19
Net Cash Growth
-15.20%-46.04%---
Net Cash Per Share
1.421.815.03-19.33-11.13
Filing Date Shares Outstanding
363.37318.59304.0280.0580.05
Total Common Shares Outstanding
363.37318.59304.0280.0580.05
Working Capital
772.94763.871,1621,0681,382
Book Value Per Share
2.443.064.44-15.57-9.88
Tangible Book Value
877.15965.841,341-1,247-790.73
Tangible Book Value Per Share
2.413.034.41-15.58-9.88
Machinery
102.2589.8974.3152.919.38
Construction In Progress
-3.112.487.230.03
Leasehold Improvements
160.09156.31148.69136.3813.16